Duopharma Biotech Bhd’s dominant market position in the local generic drug manufacturing means it is well placed to capitalise on any rise in out-of-pocket health expenditure at the pharmacies. Read full story
Date: April 10, 2025 6:00 am
Source: thestar.com.my
💬 Join the Conversation! 💬
We’ve disabled comments on our posts and pages to keep the discussions organized and lively! But don’t worry – the conversation isn’t over. Head over to our forum and share your thoughts, ideas, and feedback with the community! It’s the perfect place to connect, learn, and engage with others who care about the same things. We can’t wait to hear from you!